Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Wigfield

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 17, 2011
Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiationLudwig Dubois, Sarah Peeters, Natasja G Lieuwes, et al.
Cancer & Metabolism|July 11, 2020
Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cellsMasahiro Kawashima, Karim Bensaad, Christos E Zois, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2012
Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapyAlan McIntyre, Shalini Patiar, Simon Wigfield, et al.
Cancer & Metabolism|August 14, 2020
Correction to: Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cellsMasahiro Kawashima, Karim Bensaad, Christos E Zois, et al.
The Journal of Cell Biology|July 14, 2004
The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteinsLaura S Harrington, Greg M Findlay, Alex Gray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancerDaniele Generali, Alfredo Berruti, Maria P Brizzi, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 31, 2013
Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenograftsKrishan Kumar, Simon Wigfield, Harriet E Gee, et al.
Cell Reports|September 30, 2014
Fatty acid uptake and lipid storage induced by HIF-1α contribute to cell growth and survival after hypoxia-reoxygenationKarim Bensaad, Elena Favaro, Caroline A Lewis, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2019
Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancerMatteo Morotti, Esther Bridges, Alessandro Valli, et al.
British Journal of Cancer|December 11, 2019
Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metforminSimon R Lord, Jennifer M Collins, Wei-Chen Cheng, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 17, 2011
Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiationLudwig Dubois, Sarah Peeters, Natasja G Lieuwes, et al.
Cancer & Metabolism|July 11, 2020
Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cellsMasahiro Kawashima, Karim Bensaad, Christos E Zois, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2012
Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapyAlan McIntyre, Shalini Patiar, Simon Wigfield, et al.
Cancer & Metabolism|August 14, 2020
Correction to: Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cellsMasahiro Kawashima, Karim Bensaad, Christos E Zois, et al.
The Journal of Cell Biology|July 14, 2004
The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteinsLaura S Harrington, Greg M Findlay, Alex Gray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancerDaniele Generali, Alfredo Berruti, Maria P Brizzi, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 31, 2013
Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenograftsKrishan Kumar, Simon Wigfield, Harriet E Gee, et al.
Cell Reports|September 30, 2014
Fatty acid uptake and lipid storage induced by HIF-1α contribute to cell growth and survival after hypoxia-reoxygenationKarim Bensaad, Elena Favaro, Caroline A Lewis, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2019
Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancerMatteo Morotti, Esther Bridges, Alessandro Valli, et al.
British Journal of Cancer|December 11, 2019
Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metforminSimon R Lord, Jennifer M Collins, Wei-Chen Cheng, et al.
Pageof 3